The Real Deal: A Commentary and Examination of Xylazine Use and Unintended Consequences

Crossmark: check for updates

Authors

  • Nelson J. Tiburcio The SASSI Institute, 201 Camelot Lane, Springville, IN 47462, USA
  • Scarlett L. Baker The SASSI Institute, 201 Camelot Lane, Springville, IN 47462, USA

DOI:

https://doi.org/10.17140/sbrpoj-8-140

Abstract

In 1972, the Food and Drug Administration (FDA) granted regulatory approval for xylazine hydrochloride, a sedative intended for use in animals. This particular drug continues to hold significance for veterinarians specializing in the care of large animals such as horses, cattle, and deer

Downloads

Published

2023-12-29

How to Cite

Tiburcio, N. J., & Baker, S. L. (2023). The Real Deal: A Commentary and Examination of Xylazine Use and Unintended Consequences. Social Behavior Research and Practice, 8(2), 22–24. https://doi.org/10.17140/sbrpoj-8-140

Issue

Vol. 8 No. 2 (2023): Volume 8 Issue 2 2023

Section

Articles

License

Copyright (c) 2023 Nelson J. Tiburcio, Scarlett L. Baker

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Social Behavior Research and Practice (SBRP) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.